TransMedics Group Inc (TMDX)

NASDAQ HEALTHCARE

$78.79 +7.61% RSI 56 Neutral Add Alert

Moving Averages

SMA 200

$116.05

Price below

Company Profile

TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.

Sector

HEALTHCARE

Industry

MEDICAL DEVICES

Market Cap

$2.54B

P/E Ratio

16.84

EPS

$4.37

Beta

1.88